Literature DB >> 36017045

Advances in the research of plant-derived natural products against retinoblastoma.

Jing-Chen Liu1,2,3, Chun-Li Zhang4, Kai-Ye Dong5, Ming-Jun Li2, Shu-Guang Sun2,6, Cai-Rui Li2,5.   

Abstract

Retinoblastoma (RB) is a highly aggressive ocular tumor, and due to socioeconomic and medical constraints, many children receive treatment only in the metaphase and advanced clinical stages, resulting in high rates of blindness and disability. Although several approaches exist in the treatment of RB, some children with the disease do not have satisfactory results because of various factors. Plant-derived natural products have shown definite therapeutic effects in the treatment of various tumors and are also widely used in the study of RB. We review plant-derived natural products used in the study of anti-RB to provide ideas for the clinical application of these drugs and the development of new therapeutic drugs. International Journal of Ophthalmology Press.

Entities:  

Keywords:  apoptosis; cell cycle; drug resistance; plant-derived; retinoblastoma

Year:  2022        PMID: 36017045      PMCID: PMC9358176          DOI: 10.18240/ijo.2022.08.24

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.645


  77 in total

Review 1.  Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy.

Authors:  Bojun Wang; Tian Tian; Karl-Henning Kalland; Xisong Ke; Yi Qu
Journal:  Trends Pharmacol Sci       Date:  2018-04-17       Impact factor: 14.819

Review 2.  Neonatal Retinoblastoma.

Authors:  Frank Y Lin; Murali M Chintagumpala
Journal:  Clin Perinatol       Date:  2021-03       Impact factor: 3.430

Review 3.  Compromised MAPK signaling in human diseases: an update.

Authors:  Eun Kyung Kim; Eui-Ju Choi
Journal:  Arch Toxicol       Date:  2015-02-18       Impact factor: 5.153

4.  Neferine induces mitochondrial dysfunction to exert anti-proliferative and anti-invasive activities on retinoblastoma.

Authors:  Jing Wang; Yanmin Dong; Qiuming Li
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-28

Review 5.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

Review 6.  Bioactive lysolipids in cancer and angiogenesis.

Authors:  Yu Hisano; Timothy Hla
Journal:  Pharmacol Ther       Date:  2018-07-23       Impact factor: 12.310

7.  Pinocembrin suppresses TGF-β1-induced epithelial-mesenchymal transition and metastasis of human Y-79 retinoblastoma cells through inactivating αvβ3 integrin/FAK/p38α signaling pathway.

Authors:  Kun-Shiang Chen; Ming-Der Shi; Chi-Sheng Chien; Yuan-Wei Shih
Journal:  Cell Biosci       Date:  2014-08-12       Impact factor: 7.133

Review 8.  JAK/STAT signaling in hepatocellular carcinoma.

Authors:  Justin Jit Hin Tang; Dexter Kai Hao Thng; Jhin Jieh Lim; Tan Boon Toh
Journal:  Hepat Oncol       Date:  2020-03-18

Review 9.  Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.

Authors:  Vu Hong Loan Nguyen; Rebecca Hough; Stefanie Bernaudo; Chun Peng
Journal:  J Ovarian Res       Date:  2019-12-11       Impact factor: 4.234

Review 10.  Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications.

Authors:  Chunsik Lee; Jong Kyong Kim
Journal:  J Cell Physiol       Date:  2020-08-25       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.